They occur due to genetic mutations that disrupt the production of clotting proteins—specifically factor VIII in hemophilia A and factor IX in hemophilia B. Hemophilia A is more common, with an estimated rate of 1 case per 5000 live male births, whereas hemophilia B affects about 1 in 30,000 male births. This evidence concerns the gene F9 and hemophilia B.